These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4798401)

  • 1. Antiviral agents from fungi effective against Semliki Forest virus (SFV) in mice.
    Maheshwari RK; Gupta BM
    Indian J Med Res; 1973 Sep; 61(9):1292-8. PubMed ID: 4798401
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral effect of 3-[bis-(2-hydroxyethyl)-amino]-acetophenone-[4,5-diphenyl-oxyazolyl-(2)]hydrazone (IMET 98/69) in mice.
    Veckenstedt A; Indulen MK; Dzeguse D; Zgórniak-Nowosielska I; Mécs I; Béládi I
    Acta Virol; 1979 Nov; 23(6):500-3. PubMed ID: 44666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.
    Dimmock NJ; Kennedy SI
    J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of isoquinolines carbazoles and other miscellaneous synthetic chemicals in mice.
    Ganguly PK; Gupta BM
    Indian J Med Res; 1975 Oct; 63(10):1418-25. PubMed ID: 1222954
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of anti-semliki forest virus activity of poly N epsilon-(2-aryl-2-thiazoline-4-carbonyl-L-lysines) in mice.
    Kant R; Chandra K; Gupta BM; Mathur KB; Kishore V; Dhar MM
    Indian J Med Res; 1977 Mar; 65(3):314-9. PubMed ID: 924545
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary evidence for cell-mediated immunity in cross-protection among group A arboviruses.
    Peck RD; Brown A; Wust CJ
    J Immunol; 1975 Feb; 114(2 Pt 1):581-4. PubMed ID: 1079033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the antiviral activity of inorganic heteropolyanions against Semliki forest virus in vivo and vaccinia virus in vitro.
    George CX; Singh C; Ram SN; Yadav KD; Sharma B
    Acta Virol; 1990 Aug; 34(4):330-8. PubMed ID: 1981443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon as an antiviral agent in vivo: quantitative and temporal aspects of the protection of mice against Semliki Forest virus.
    Finter NB
    Br J Exp Pathol; 1966 Aug; 47(4):361-71. PubMed ID: 5917346
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of irradiation on demyelination induced by avirulent Semliki Forest virus.
    Chew-Lim M; Webb HE; Jagelman S
    Br J Exp Pathol; 1977 Oct; 58(5):459-64. PubMed ID: 588439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral profile of Nyctanthes arbortristis L. against encephalitis causing viruses.
    Gupta P; Bajpai SK; Chandra K; Singh KL; Tandon JS
    Indian J Exp Biol; 2005 Dec; 43(12):1156-60. PubMed ID: 16359127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluations of tilorone hydrochloride against Semliki Forest virus.
    Krueger RF; Mayer GD; Yoshimura S; Ludwig KA
    Antimicrob Agents Chemother (Bethesda); 1970; 10():486-90. PubMed ID: 5521373
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of interferon induction in mice by polycationic modified polypeptides.
    Mécs I; Gánti T; Kótai A
    Acta Virol; 1976 Apr; 20(2):164-6. PubMed ID: 5874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral agent (6-MFA) from Aspergillus ochraceus--sensitivity of arboviruses in experimentally infected mice.
    Maheshwari RK; Gupta BM; Ghosh SN; Gupta NP
    Indian J Med Res; 1978 Feb; 67():183-9. PubMed ID: 680873
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of hyperthermia and poly I:C on Semliki Forest virus infection in mice.
    Teisner B; Mogensen SC; Haahr S
    Arch Virol; 1975; 48(3):253-9. PubMed ID: 1180698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.
    Thomson M; White CL; Dimmock NJ
    Virology; 1998 Feb; 241(2):215-23. PubMed ID: 9499796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-viral activity against encephalomyocarditis virus and Semliki Forest virus and acute toxicity of poly I and poly C administered sequentially to mice.
    Stebbing N; Grantham CA
    Arch Virol; 1976; 51(3):199-215. PubMed ID: 184760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection patterns in mice of an avirulent and virulent strain of Semliki Forest virus.
    Pusztai R; Gould EA; Smith H
    Br J Exp Pathol; 1971 Dec; 52(6):669-77. PubMed ID: 5135538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoracic duct lymph and blood of mice at early stages of Tahyńa and Semliki Forest virus infections.
    Wallnerová Z
    Acta Virol; 1973 Nov; 17(6):511. PubMed ID: 4150036
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and antiviral activity of 3-(beta-D-ribofuranosyl)-1,2,4-oxadiazole-5-carboxamide.
    Pratap R; Yarovenko VN
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(5-6):845-9. PubMed ID: 10893705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro heterologous cytotoxicity by T effector cells from mice immunized with Sindbis virus.
    Peck R; Brown A; Wust CJ
    J Immunol; 1979 Oct; 123(4):1763-6. PubMed ID: 314471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.